Benign Prostatic Hyperplasia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.The Combined Effect of Intravesical Botox Injections and HoLEP Surgery in Treating Benign Prostatic Hyperplasia and Overactive Bladder
Conditions: Benign Prostatic Hyperplasia; Overactive Bladder Intervention: Drug: Intravesical Botox injection Sponsor: University Hospitals Cleveland Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 26, 2022 Category: Research Source Type: clinical trials
